Short Interest in MariMed Inc. (OTCMKTS:MRMD) Declines By 75.0%

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 16,030 shares, a decrease of 75.0% from the May 31st total of 64,138 shares. Based on an average trading volume of 1,406,144 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

MariMed Stock Performance

Shares of OTCMKTS MRMD opened at $0.07 on Friday. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The company has a market cap of $28.02 million, a P/E ratio of -2.34 and a beta of 1.30. The firm’s fifty day moving average is $0.08 and its two-hundred day moving average is $0.08. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. The business had revenue of $39.48 million during the quarter, compared to the consensus estimate of $38.75 million. As a group, analysts anticipate that MariMed will post -0.04 EPS for the current fiscal year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.